The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease

The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease

The most important function of the intestinal mucosa is to form a barrier that separates luminal contents from the intestine. Defects in the intestinal epithelial barrier have been observed in several intestinal disorders such as inflammatory bowel disease (IBD). Recent studies have identified a num...

Full description

Bibliographic Details
Main Authors:	Maja Stojancevic, Karmen Stankov, Momir Mikov
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2012/538452

Similar Items

Probiotics as a promising treatment for inflammatory bowel disease
by: Mikov Momir M., et al.
Published: (2014-01-01)

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.
by: Rian M Nijmeijer, et al.
Published: (2011-01-01)

Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases
by: Jin-nan Wu, et al.
Published: (2020-01-01)

The Farnesoid X Receptor: Good for BADSummary
by: Stephen J. Keely, et al.
Published: (2016-11-01)

Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis MiceSummary
by: Pauline T. Ikpa, et al.
Published: (2020-01-01)

Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats.
by: Laurens J Ceulemans, et al.
Published: (2017-01-01)

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
by: Insook Kim, et al.
Published: (2007-12-01)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
by: Chao Li, et al.
Published: (2020-08-01)

The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion
by: Jiro Ogura, et al.
Published: (2012-11-01)

Farnesoid X receptor (FXR): Structures and ligands
by: Longying Jiang, et al.
Published: (2021-01-01)

Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases
by: Sung Hee Lee
Published: (2015-01-01)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
by: Sharon Manley, et al.
Published: (2015-03-01)

The role of bile acids and farnesoid X receptor in ileal Crohn's disease
by: Speight, Richard Alexander
Published: (2015)

Functional Food Components, Intestinal Permeability and Inflammatory Markers in Patients with Inflammatory Bowel Disease
by: Joana Franco Lacerda, et al.
Published: (2021-02-01)

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
by: Raffaella Maria Gadaleta, et al.
Published: (2020-04-01)

Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-β
by: Sandra M.W. van de Wiel, et al.
Published: (2018-01-01)

Molecular tuning of farnesoid X receptor partial agonism
by: Daniel Merk, et al.
Published: (2019-07-01)

Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
by: Yingfei Xi, et al.
Published: (2020-01-01)

Corrigendum to ‘Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor’
by: Raffaella Maria Gadaleta, et al.
Published: (2020-07-01)

Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor
by: Kevin M Tveter, et al.
Published: (2020-04-01)

Allosteric modulation of the farnesoid X receptor by a small molecule
by: Matthias Gabler, et al.
Published: (2018-05-01)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
by: Hong Li, et al.
Published: (2019-05-01)

Farnesoid X receptor represses hepatic lipase gene expression
by: Audrey Sirvent, et al.
Published: (2004-11-01)

Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
by: Andrea Michielan, et al.
Published: (2015-01-01)

Computational studies of nuclear receptors : estrogen receptors, glucocorticoid receptors, and farnesoid X receptor
by: Chu, Kwun Pok
Published: (2009)

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
by: Joana Torres, et al.
Published: (2017-10-01)

Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
by: Guodong Li, et al.
Published: (2015-03-01)

Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
by: Sun-Gi Kim, et al.
Published: (2016-12-01)

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
by: Ludovico Abenavoli, et al.
Published: (2020-06-01)

Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development
by: Shogo Takahashi, et al.
Published: (2018-12-01)

Tissue specific induction of p62/Sqstm1 by farnesoid X receptor.
by: Jessica A Williams, et al.
Published: (2012-01-01)

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
by: Sosmitha Girisa, et al.
Published: (2021-07-01)

The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
by: Takuo Suzuki, et al.
Published: (2008-01-01)

On the Pharmacology of Farnesoid X Receptor Agonists: Give me an “A”, Like in “Acid”
by: Eva Hambruch, et al.
Published: (2016-06-01)

Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets
by: Syeda Maliha, et al.
Published: (2021-09-01)

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin
by: Miao Hu, et al.
Published: (2012-07-01)

Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor
by: Tomoko Nishimaki-Mogami, et al.
Published: (2004-08-01)

Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
by: Sosmitha Girisa, et al.
Published: (2020-10-01)

Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
by: Anca D. Petrescu, et al.
Published: (2021-07-01)

JAK-STAT Pathway Regulation of Intestinal Permeability: Pathogenic Roles and Therapeutic Opportunities in Inflammatory Bowel Disease
by: Hillmin Lei, et al.
Published: (2021-08-01)